A detailed history of Vr Adviser, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 5,555,555 shares of AQST stock, worth $19.6 Million. This represents 2.87% of its overall portfolio holdings.

Number of Shares
5,555,555
Previous 5,555,555 -0.0%
Holding current value
$19.6 Million
Previous $14.4 Million 91.54%
% of portfolio
2.87%
Previous 1.58%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.01 - $6.09 $11.2 Million - $33.8 Million
5,555,555 New
5,555,555 $23.7 Million

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $188M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.